CBER Expertise

Office of Cellular, Tissue and Gene Therapies

Raj K. Puri, MD, PhD, Director
Kimberly A. Benton, PhD, Deputy Director

Gene Transfer and Immunogenicity Branch

Eda T. Bloom, PhD, Chief - Evaluating and predicting the effects on safety and efficacy of immune responses to cell therapy and xenotransplantation products
Suzanne L. Epstein, PhD - Reduction of virus infection by immunity induced by vaccines or vectors
Carolyn A. Wilson, PhD - Viral safety studies in xenotransplantation and gene therapy products
Andrew Byrnes, PhD - Safety and efficiency of gene therapy

Tumor Vaccines and Biotechnology Branch

Raj Puri, MD, PhD, Acting Chief - Development of safe and effective tumor vaccines and gene therapy products
Michail A. Alterman, PhD - Analytical proteomics as a tool for the characterization of biologic products and discovery and validation of biomarkers.

Cellular and Tissue Therapy Branch

Steven R. Bauer, PhD, Acting Chief - Assuring safety and efficacy of stem-cell based products
Brenton McCright, PhD - Developing measures of safety and efficacy for tissue-engineered products
Malcolm Moos, MD, PhD - Predicting the safety and efficacy of cell and tissue products used for repair of damaged tissue and structures through cell growth and maturation pathways
Deborah Hursh, PhD - Developing predictive indicators of cell maturation as indicators of cell therapy product efficacy and safety
Gerald Marti, MD - Flow cytometry: a way to characterize cell populations